Publicacions en què col·labora amb José Luis Lanciego Pérez (14)

2020

  1. Expression of GPR55 and either cannabinoid CB1 or CB2 heteroreceptor complexes in the caudate, putamen, and accumbens nuclei of control, parkinsonian, and dyskinetic non-human primates

    Brain Structure and Function, Vol. 225, Núm. 7, pp. 2153-2164

  2. Expression of cannabinoid CB1R–GPR55 heteromers in neuronal subtypes of the Macaca fascicularis striatum

    Annals of the New York Academy of Sciences, Vol. 1475, Núm. 1, pp. 34-42

2019

  1. Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease

    Molecular Neurobiology, Vol. 56, Núm. 8, pp. 5900-5910

2017

  1. Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors

    Frontiers in Pharmacology, Vol. 8, Núm. OCT

  2. Neurochemical evidence supporting dopamine D1–D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation

    Brain Structure and Function, Vol. 222, Núm. 4, pp. 1767-1784

2016

  1. Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization

    Frontiers in Pharmacology, Vol. 7, Núm. MAR

  2. Two affinity sites of the cannabinoid subtype 2 receptor identified by a novel homogeneous binding assay

    Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 3, pp. 580-587

2015

  1. Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism

    Brain Structure and Function, Vol. 220, Núm. 5, pp. 2721-2738

  2. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum

    Biochemical Pharmacology, Vol. 96, Núm. 2, pp. 131-142

2014

  1. CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum

    Experimental Neurology, Vol. 261, pp. 44-52

  2. G-Protein-Coupled Receptor Heteromers as Key Players in the Molecular Architecture of the Central Nervous System

    CNS Neuroscience and Therapeutics, Vol. 20, Núm. 8, pp. 703-709

  3. GPR40 activation leads to CREB and ERK phosphorylation in primary cultures of neurons from the mouse CNS and in human neuroblastoma cells

    Hippocampus, Vol. 24, Núm. 7, pp. 733-739

  4. L-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies

    Experimental Neurology, Vol. 253, pp. 180-191

  5. L-DOPA-treatment in primates disrupts the expression of A2A adenosine-CB1 cannabinoid-D2 dopamine receptor heteromers in the caudate nucleus

    Neuropharmacology, Vol. 79, pp. 90-100